Latest Rheumatology Stories
INDIANAPOLIS, Jan. 3, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that Michael P. Heffernan, M.D., a nationally recognized expert in complex medical dermatology, psoriasis and clinical trials, has joined its autoimmune team as distinguished medical fellow. Alisa E. Koch, M.D., a rheumatologist who has won numerous academic awards for her extensive work in rheumatoid arthritis, joined as senior medical fellow. Most recently, Heffernan was in private practice at...
ANAHEIM, Calif., Jan. 3, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 10, 2013 at 9:00 a.m. PT / 12:00 p.m. ET. A live webcast with accompanying slide presentation, and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The replay will be...
A recently added market report by Transparency Market Research on “Autoimmune Treatment Market - Global Market Scenario, Trends, Industry Analysis And Forecast, 2012 - 2018" is now available for pre order. To Browse the report visit: http://www.transparencymarketresearch.com/autoimmune-treatment-market.html Albany, New York (PRWEB) December 31, 2012 Autoimmune diseases occur because of the body’s hyperactive immune response in relation to the tissues and substances normally...
Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study which looks at the effect of specific biomaterials on joint and knee replacements. New York, NY;Washington, DC;Los Angeles-Long Beach, CA;Chicago, IL;Houston, TX (PRWEB) December 31, 2012 -- Toronto, ON (PRWEB), Dec 31, 2012 – Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, is...
"Osteoarthritis of the knee is now being treated with regenerative medicine at he center for regenerative medicine." according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for regenerative medicine. (PRWEB) December 29, 2012 "Osteoarthritis of the knee is now being treated with regenerative medicine at he center for regenerative medicine." according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for...
Researchers at Rush University Medical Center, in collaboration with researchers at Northwestern University, have identified a molecular mechanism central to the development of osteoarthritis (OA) pain, a finding that could have major implications for future treatment of this often-debilitating condition. “Clinically, scientists have focused on trying to understand how cartilage and joints degenerate in osteoarthritis. But no one knows why it hurts,” said Dr. Anne-Marie Malfait,...
ATLANTA, Dec. 20, 2012 /PRNewswire-USNewswire/ -- The Arthritis Foundation recently elected Daniel T. McGowan as chair of its National Board of Directors at its annual meeting in Colorado Springs, Colo. The Foundation also appointed Laurie Stewart and Suzanne Taylor as new board members. They bring to the Arthritis Foundation their vast experiences in health care, banking and business ownership, as well as valuable perspectives from their many years of community service. (Photo:...
EAST HANOVER, N.J., Dec. 19, 2012 /PRNewswire/ -- The New England Journal of Medicine (NEJM) published today the results of two Phase III trials, and both show ACZ885 (canakinumab) provided substantial symptom relief in young patients with systemic juvenile idiopathic arthritis (SJIA).(1) In addition, ACZ885 delayed disease flare recurrence and allowed patients to substantially reduce or discontinue use of corticosteroids.(1) ACZ885 is a Novartis compound being studied for use...
Life Control Software, Inc., a leading provider of smartphone software for chronic pain management, was recognized for its popular Android app, Manage My Pain. Manage My Pain was the only recipient of a Web Health Award in the Chronic Disease Management category. Toronto, Ontario (PRWEB) December 18, 2012 Life Control Software was recognized with an award for its popular Android app, Manage My Pain at 14th annual Web Health Awards(SM) program. “We are honoured to have been selected as...
WOBURN, Mass., Dec. 17, 2012 /PRNewswire/ -- Flexion Therapeutics, Inc. today reported that FX006, its novel intra-articular, sustained release steroid, maintained therapeutic concentrations in the knee joint significantly longer than the most commonly prescribed immediate release (IR) steroid, triamcinolone acetonide (TCA) in a Phase 2 pharmacokinetic study. At six weeks, FX006, a sustained release formulation of TCA, remained in the joint at clinically active concentrations while...
